Industry News

AlloSource Signs Space Act Agreement With NASA And Jet Propulsion Laboratory Technology used in NASA Mars missions will provide insights into microbial testing related to tissue processing
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
EYLEA (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by year end
Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease
Nektar says FDA clears constipation drug Movantik
Walgreens Boots Alliance Files Form S-4 Registration Statement and Preliminary Proxy Statement/Prospectus Related to Walgreens Strategic Transaction with Alliance Boots
FDA Warns Against Non-approved Dermal Filler
Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease
EYLEA� (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by year end
Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott
FDA Warns Against Non-approved Dermal Filler
Baxter Initiates U.S. Voluntary Recall of One Lot of Potassium Chloride Injection Due to Shipping Carton Mislabeling
California biotech firm to hire 100-plus to make cancer drugs in University Research Park
Nobel Biocare to Join Danaher Dental Platform
FDA Oks New Indication for the Use of XTANDI (enzalutamide) Capsules
Lannett Reports FDA Approval of Oxycodone Hydrochloride Oral Solution
Kolltan Pharmaceuticals Buys Xetrios Therapeutics
YourEncore Debuts Quality Center of Excellence
MEDIPOST America clears Phase 1/2 IND for the U.S. clinical trial on stem cell drug for lung
Merck's new tool in cancer fight
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent - Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent
United States : FDA Approves Baxter's HYQVIA for Treatment of Adults with Primary Immunodeficiency
FDA denies Amarin appeal, stock plunges
Lilly Announces CYRAMZA Phase III Meets Primary Endpoint Of Overall Survival; FDA Advisory Committee to Review Natpara Biologics License Application-Halts NPS Pharma Trading
FDA Approves Baxter�s HYQVIA for Treatment of Adults with Primary Immunodeficiency